文献速递呼吸衰竭与机械通气消化、代谢与肾脏急症

急诊MRSA鼻拭子PCR对肺炎万古霉素与利奈唑胺疗程的影响

Impact of MRSA nasal PCR in the emergency department on duration of vancomycin and linezolid for pneumonia
RSS 订阅 · Am J Emerg Med · 2026-10-26
一句话结论在急诊由药师驱动MRSA鼻拭子PCR送检,可将疑诊肺炎并入住病房患者的抗MRSA治疗中位时长由5.90小时降至1.13小时(p=0.006),且30天再入院率与30天全因死亡率未增加。

该研究为单中心准实验非等效对照研究,纳入急诊疑诊肺炎并接受抗MRSA治疗且后续入院的成人患者,比较药师驱动MRSA鼻拭子PCR送检策略实施前后抗MRSA治疗时长。结果显示抗MRSA治疗中位时长由干预前5.90小时降至干预后1.13小时(p=0.006),MRSA鼻拭子PCR送检率由69.4%升至86.3%(p=0.18),住院中位天数5.0天对6.0天无显著差异(p=0.10)。结论认为药师参与急诊抗菌药物管理可显著缩短抗MRSA治疗时长,且未对30天再入院率和30天全因死亡率产生不良影响。

要点

  • 急诊疑诊肺炎并接受抗MRSA治疗且随后入院的成人患者,药师按既有院内方案驱动MRSA鼻拭子PCR送检后,抗MRSA治疗中位时长由5.90小时降至1.13小时(p=0.006)。
  • MRSA鼻拭子PCR送检率由干预前69.4%升至干预后86.3%(p=0.18),组间差异未达统计学显著。
  • 住院中位天数干预前5.0天对干预后6.0天,差异无统计学显著(p=0.10)。
  • 作者结论认为药师驱动的急诊MRSA鼻拭子PCR送检显著缩短抗MRSA治疗时长,且未对30天再入院率或30天全因死亡率产生不良影响。

适用人群与场景

  • 急诊疑诊肺炎、在急诊接受抗MRSA治疗并随后入院的成人患者。

处置流程与药物剂量

  • 急诊药师按既有院内方案负责开具MRSA鼻拭子PCR医嘱,急诊护士协助在急诊完成鼻拭子采集。
  • 干预后组(药师驱动送检策略实施后)抗MRSA治疗中位时长为1.13小时,干预前组为5.90小时。

研究设计与关键结果

  • 研究类型为单中心准实验非等效对照研究,使用电子健康记录数据,共纳入200例成人急诊疑诊肺炎、接受抗MRSA治疗并随后入院的患者。
  • 抗MRSA治疗中位时长干预前组5.90小时对干预后组1.13小时(p=0.006)。
  • MRSA鼻拭子PCR送检率干预前69.4%对干预后86.3%(p=0.18)。
  • 住院中位天数干预前组5.0天对干预后组6.0天,差异无统计学显著(p=0.10)。

证据类型、等级与局限

  • 证据类型:单中心准实验非等效对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在急诊疑诊肺炎并启动抗MRSA治疗的成人患者中,由药师按既有院内方案驱动MRSA鼻拭子PCR送检,可缩短抗MRSA治疗时长。
  • 作者认为药师参与急诊抗菌药物管理具有价值。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Methicillin-resistant Staphylococcus aureus (MRSA) is a common cause of nosocomial pneumonia, often prompting empiric anti-MRSA therapy despite low prevalence in emergency department (ED) presentations. MRSA nasal polymerase chain reaction (PCR) offers a rapid, non-invasive method to guide de-escalation of MRSA-targeted therapy. This study aims to evaluate the impact of pharmacist-driven MRSA nasal PCR ordering in the ED on the duration of anti-MRSA therapy.

METHODS: We conducted a quasi-experimental non-equivalent control study at a single academic center using data from an electronic health record. Adult ED patients with suspected pneumonia who received anti-MRSA therapy in the ED and were subsequently admitted were included. Emergency department pharmacists were responsible for ordering MRSA nasal PCR in compliance with a pre-existing hospital protocol. ED nurses facilitated MRSA nasal PCR collection in the ED.

RESULTS: A total of 200 patients were included in the final analysis. The median duration of anti-MRSA therapy was 5.90 h and 1.13 h for pre- and post-intervention groups, respectively (p = 0.006). Incidence of MRSA nasal PCRs ordered increased from 69.4% pre-intervention to 86.3% post-intervention (p = 0.18). Median length of hospital stay was not significantly different between groups (5.0 days vs. 6.0 days, p = 0.10).

CONCLUSIONS: Pharmacist-driven MRSA nasal PCR ordering in the ED significantly reduced anti-MRSA therapy duration without adversely affecting 30-day readmission rates or all-cause 30-day mortality. These findings highlight the value of pharmacist engagement in antibiotic stewardship in the ED.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Am J Emerg Med:Impact of MRSA nasal PCR in the emergency department on duration of vancomycin and linezolid for pneumonia
  2. Skaar SM, Wex N, Wehling H, et al. Impact of MRSA nasal PCR in the emergency department on duration of vancomycin and linezolid for pneumonia. Am J Emerg Med. 2026. PMID: 42994388. doi:10.1016/j.ajem.2026.10.016

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。